GlaxoSmithKline submits regulatory application for UMEC/VI

A.B. | ShareCast | 18 Dec, 2012 12:05 - Updated: 12:58 | | |

needle
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a
  • n/a
  • n/an/a
  • Max: n/a
  • Min: n/a
  • Volumen: n/a
  • MM 200 : n/a
n/a

Pharmaceutical companies GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for UMEC/VI medicine, used to treat chronic obstructive pulmonary disease (COPD).

UMEC/VI is an investigational once-daily LAMA/LABA combination medicine. It includes properties, umeclidinium bromide --- a long-acting muscarinic antagonist (LAMA)--- and vilanterol, a long-acting beta2 agonist which is administered using the Ellipta inhaler.

The application proposes the proprietary name Anora Ellipta and has been submitted to the US Food and Drug Administration for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.

Applications for UMEC/VI are also planned in the European Union and in other countries next year.

FSTE 100 company GSK is a leading research-based pharmaceutical and healthcare company.

Theravance is a biopharmaceutical company which collaborates with a number of pharmaceutical organisations.

RD

More news

30 Jan US close: Stocks fall sharply after disappointing GDP

US stocks fell sharply on Friday, after government data showed economy slowed down more than anticipated in the fourth quarter, while oil prices staged an unexpected revival.

30 Jan Amazon's CEO pockets almost $3bn as shares surge 15%

Shares in Amazon rose over 14% on Friday and the surge has boosted the online retailing giant's market value by about $16.5bn

30 Jan Crude futures settle over than 8% higher on Friday

30 Jan Crude futures soar over 6%

30 Jan Fed must hike rates sooner or risks falling behind the curve, says Bullard

St Louis Federal Reserve president, James Bullard, said the Fed should not delay its decision to hike interest rates for much longer as it risks falling behind the curve.

30 Jan Peace talks in Ukraine suffer latest setback as civilians are killed

Peace talks in Ukraine suffered a new setback on Friday, while civilians were killed on both sides during heavy fighting.

30 Jan Deloitte appeal against MG Rover misconduct charges is successful

Accounting firm Deloitte has had a series of misconduct rulings successfully overturned.

30 Jan 'Grexit' may be necessary to save Spain and avoid 'Spexit', says WSJ

The newly-formed Greek government led by anti-austerity party Syriza began negotiations with the Eurozone on Friday over the future of its financial support programme. The international financial press had already echoed titles not seen since the 2012 crisis by bringing back the question of whether Greece should stay or go in the single-bloc currency and what the implications are for Spain.

30 Jan FTSE 250 movers: Afren soars on extended Seplat deadline

Oil producer Afren was continuing its volatile moves, jumping 33.33%. Afren extended their ‘put up or shut up’ deadline, initially set for Friday, to Nigerian producer Seplat by a further two weeks, in line with some analyst expectations.

30 Jan FCA launches probe into Deutsche Bank's London office

The Financial Conduct Authority (FCA) has opened an investigation into the London office of German bank Deutsche Bank over governance and controls concerns.